CompletedNCT06044818
Validation of Accexible as a Tool for Screening and Monitoring Depression.
Observational studyAges 18–65Spain
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- BarcelonaSee all locations and recruitment
Study information
Study start dateStarted: July 10, 2023
- Recruitment status
- Completed
- Enrollment listed in the registry
- 166
- Sponsor
- Accexible
- Sponsor type
- Unknown or unclear
- Study type
- Observational
- Intervention type
- DEVICE
- Study phase
- Not clearly listed
- Locations
- Spain
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT06044818
- Official title
Show the full official title
Validación Del Sistema de Cribaje y Seguimiento de acceXible Para depresión.
Recruitment & locations
CompletedBarcelona
Questions about this study
Who is behind this study?
The study sponsor is Accexible.
Who was this study for?
Listed age limits: 18 years to 65 years.
Want to find a study that may fit you better?
Explore HopeStage studies by mental health topic and refine the results to suit your situation.
Find a study that may fit meRelated studies
A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI)
Clinical Validation Study for EDIT-B Test: an Aid for Differential Diagnosis of Bipolarity, Based on RNA Editing Blood Biomarkers